Press Releases

• Heilbronn, Germany – August 15th, 2008

  Greenovation Biotech enters into antibody glyco-engineering contract with Merck Serono.

  Greenovation Biotech today announced that it has entered into an agreement with Merck Serono, a division of Merck KGaA, Darmstadt, Germany, to evaluate antibody optimization and production in greenovation’s Bryotechnology platform.

  DetailsDownload
• Heilbronn, Germany – August 28th, 2008

  greenovation increases investment in GMP-compliant process development for the production of therapeutic proteins for the pharmaceutical industry

  The primary objective of the investment is the implementation of a stable production platform for the manufacture of glycoproteins for industrial pharmaceutical applications, in accordance with GMP (Good Manufacturing Practice) guidelines - Gregor Mirow succeeds Hans Bodo Hartmann as the new managing director of greenovation Biotech GmbH

  DetailsDownload
• Heilbronn – June 3, 2008

  Arana and Greenovation to cooperate in development of innovative anti-cancer antibodies

  • Combination of platforms to deliver pipeline of next generation antibodies
  • Arana to select antibodies to which Greenovation technology is to be applied

  DetailsDownload